Competition for pharmaceutical government contracts rises


According to UOBKH, Duopharma’s management had said before that it would like to maintain earnings contribution from the government by winning a larger slice of the Health Ministry’s (MoH) contracts at lower margins

PETALING JAYA: Competition for government contracts among generic producers will be heightened even as the deadline for tenders by the end of the year draws near, says UOB Kay Hian Research (UOBKH).

“We gather that Pharmaniaga Bhd is ready to tender for 25 additional and new products. Tenders had historically ranged between RM40mil and RM60mil per tender, ” it said.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

A good deal for AmBank, but AmFirst?
Blooming Chinese beauty sector
Money-market funds are retail’s hot trade
The economics of rooftop solar power
LYC�– from Nasdaq dreams to GN3
S-REIT appeal builds up
Dubai Chocolate faces pistachio crunch
Betting on boom�–�and bust
Shanghai eyes asset hub status
China leads global EV race

Others Also Read